EcoDrugPlus

Ensembl ID : ENSVPAG00000004602
Gene Symbol: -
Cross references: -
214 Possible Orthologues:

Ensembl ID : ENSVPAG00000004586
Gene Symbol: -
Cross references: -
226 Possible Orthologues:

Ensembl ID : ENSVPAG00000004466
Gene Symbol: -
Cross references: -
102 Possible Orthologues:

Ensembl ID : ENSVPAG00000004220
Gene Symbol: -
Cross references: -
243 Possible Orthologues:

Ensembl ID : ENSVPAG00000003928
Gene Symbol: -
Cross references: -
226 Possible Orthologues:

Ensembl ID : ENSVPAG00000003687
Gene Symbol: -
Cross references: -
312 Possible Orthologues:

Ensembl ID : ENSVPAG00000003494
Gene Symbol: -
Cross references: -
205 Possible Orthologues:

Ensembl ID : ENSVPAG00000002760
Gene Symbol: -
Cross references: -
203 Possible Orthologues:

Ensembl ID : ENSVPAG00000002756
Gene Symbol: -
Cross references: -
229 Possible Orthologues:

Ensembl ID : ENSVPAG00000002755
Gene Symbol: -
Cross references: -
269 Possible Orthologues:

Ensembl ID : ENSVPAG00000002689
Gene Symbol: -
Cross references: -
217 Possible Orthologues:

Ensembl ID : ENSVPAG00000002684
Gene Symbol: -
Cross references: -
200 Possible Orthologues:

Select Keywords:


PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains. Elements of the website have been developed under projects from the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).

PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains.

Elements of the website have been developed under projects from the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).